Discover
KYNB
Kyntra Bio, Inc.
7.55
1 x 7.43
2 x 6.99
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
7.55 +0.00 (0.00%)
| Ytd | -14.01% | |
| 1y | 43.26% |
7.37
day range
7.60
5.20
52 week range
12.60
| Open | 7.59 | Prev Close | 7.55 | Low | 7.37 | High | 7.60 | Mkt Cap | 30.56M |
| Vol | 4.65K | Avg Vol | 17.93K | EPS | -13.99 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 6.98 | 200-d Avg | 8.44 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 3.74M | ||
| Revenues (USD) | 3.74M | ||
| Cost of Revenue | 4.11M | ||
| Gross Profit | -368.00K | ||
| Operating Expenses | 13.45M | ||
| Research and Development Expense | 7.57M | ||
| Selling, General and Administrative Expense | 5.86M | ||
| Operating Income | -13.82M | ||
| Interest Expense | 2.43M | ||
| Net Income | -15.20M | ||
| Net Income Common Stock | -15.20M | ||
| Net Income Common Stock (USD) | -15.20M | ||
| Consolidated Income | -15.20M | ||
| Net Income from Discontinued Operations | 66.00K | ||
| Earnings per Basic Share | -3.76 | ||
| Earnings per Basic Share (USD) | -3.76 | ||
| Earnings per Diluted Share | -3.76 | ||
| Earning Before Interest & Taxes (EBIT) | -12.77M | ||
| Earning Before Interest & Taxes (USD) | -12.77M | ||
| Weighted Average Shares | 4.05M | ||
| Weighted Average Shares Diluted | 4.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 37.00M | ||
| Cash and Equivalents (USD) | 37.00M | ||
| Investments | 58.27M | ||
| Investments Current | 50.24M | ||
| Investments Non-Current | 8.03M | ||
| Trade and Non-Trade Receivables | 5.04M | ||
| Current Assets | 101.36M | ||
| Total Assets | 109.63M | ||
| Total Debt | 67.41M | ||
| Current Liabilities | 28.11M | ||
| Debt Non-Current | 67.41M | ||
| Total Liabilities | 118.92M | ||
| Accumulated Retained Earnings (Deficit) | -1.72B | ||
| Accumulated Other Comprehensive Income | -1.89M | ||
| Shareholders Equity | -43.80M | ||
| Shareholders Equity (USD) | -43.80M | ||
| Assets Non-Current | 8.27M | ||
| Total Debt (USD) | 67.41M | ||
| Deferred Revenue | 9.76M | ||
| Inventory | 3.38M | ||
| Liabilities Non-Current | 90.81M | ||
| Trade and Non-Trade Payables | 5.09M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.00K | ||
| Net Cash Flow from Financing | -7.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.87M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -60.00K | ||
| Net Cash Flow from Investing | 3.02M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 3.08M | ||
| Net Cash Flow from Operations | -13.89M | ||
| Effect of Exchange Rate Changes on Cash | 1000 | ||
| Share Based Compensation | 1.15M | ||